Myelodysplastic Syndromes
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndromes.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2015-08-31Clinical Trial Update: A Phase I Trial of Alloreactive Cell Infusion Following Transplantation of Haplotype Cells in Patients With Myeloid Malignancies [Phase 1]
A Phase I study of an alloreactive cell infusion following transplantation of haplotype cells in patients with myeloid malignancies has been…
-
CLINICAL_TRIALS withdrawal · 2015-06-08Clinical Trial Update: Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment [Phase 1]
Phase 1 trial evaluating total marrow and total lymph node irradiation with fludarabine and melphalan followed by donor stem cell transplant…
-
CLINICAL_TRIALS withdrawal · 2015-05-29Clinical Trial Update: Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers
A clinical trial evaluating perceived burden in late-stage cancer patients and their caregivers has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-03-06Clinical Trial Update: Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant [Phase 1, Phase 2]
A Phase 1/2 clinical trial on preventing graft-versus-host disease in patients with hematologic malignancies undergoing bone marrow transpla…
-
CLINICAL_TRIALS withdrawal · 2014-12-11Clinical Trial Update: Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors [NA]
This clinical trial update indicates that Vanderbilt University’s study on early enteral tube feedings for children undergoing chemotherapy …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2014-12-04Clinical Trial Update: OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies [Phase 2]
A Phase 2 clinical trial (OTI-010) evaluating prophylaxis against graft-versus-host disease in patients undergoing donor peripheral blood st…
-
CLINICAL_TRIALS withdrawal · 2014-03-20Clinical Trial Update: Azacitidine With or Without Ceplene/Interleukin-2 in Patients With Higher Risk Myelodysplastic Syndromes [Phase 1, Phase 2]
A Phase 1/2 trial investigating azacitidine with or without Ceplene (histamine dihydrochloride) and interleukin-2 for higher-risk myelodyspl…
-
CLINICAL_TRIALS withdrawal · 2014-02-11Clinical Trial Update: AMD3100 With Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplant for AML and MDS [Phase 1, Phase 2]
A Phase 1/2 trial evaluating AMD3100 with busulfan, fludarabine, and thymoglobulin for allogeneic stem cell transplantation in acute myeloid…
-
CLINICAL_TRIALS withdrawal · 2013-10-01Clinical Trial Update: Study of Clofarabine in Combination With Low Dose Cytarabine to Treat Myelodysplastic Syndromes [Phase 2]
A Phase 2 trial evaluating clofarabine in combination with low-dose cytarabine for myelodysplastic syndromes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-04-18Clinical Trial Update: An Expanded Access Program for Decitabine in Patients With Myelodysplastic Syndrome (MDS)
This notice indicates that Janssen-Cilag's expanded access program using decitabine for myelodysplastic syndromes is no longer available.
-
CLINICAL_TRIALS withdrawal · 2013-04-02Clinical Trial Update: Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer [NA]
Clinical trial evaluating Aprepitant and Ondansetron for opioid-induced nausea and vomiting in cancer patients; the study was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-02-15Clinical Trial Update: Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies [Phase 1, Phase 2]
Clinical trial update notes the withdrawal of a Phase 1/2 study evaluating antimicrobial versus saline solutions to maintain catheter patenc…
-
CLINICAL_TRIALS withdrawal · 2013-02-04Clinical Trial Update: Influence of Exercise on Anemia in MDS Patients [Phase 1, Phase 2]
A Phase 1/2 feasibility trial evaluated whether exercise could influence anemia in patients with myelodysplastic syndromes, but the study wa…
-
CLINICAL_TRIALS withdrawal · 2012-10-02Clinical Trial Update: Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 study of busulfan and fludarabine conditioning before donor stem cell transplant for hematologic cancers has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-07-11Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic Syndrome [Phase 2]
Phase 2 clinical trial evaluating monoclonal antibody therapy for myelodysplastic syndromes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-07-09Clinical Trial Update: Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant [NA]
A clinical trial evaluating mechanical stimulation to prevent bone density loss in patients undergoing donor stem cell transplant has been w…
-
CLINICAL_TRIALS withdrawal · 2012-06-20Clinical Trial Update: Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia [Phase 1]
A Phase 1 trial of recombinant human Mannose-Binding Lectin (MBL) in young patients with MBL deficiency and fever with neutropenia was withd…
-
CLINICAL_TRIALS withdrawal · 2011-06-28Clinical Trial Update: Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes [Phase 2]
A Phase 2 trial evaluating the combination of arsenic trioxide and ascorbic acid in myelodysplastic syndromes was terminated.
-
CLINICAL_TRIALS withdrawal · 2011-04-28Clinical Trial Update: Creation of Bone Marrow Microenvironment for Treatment of Myelodysplastic Syndrome (MDS) in Conjunction With Allogeneic Stem Cell Transplantation [Phase 2]
The Phase 2 trial investigating the creation of a bone marrow microenvironment to treat myelodysplastic syndromes in conjunction with alloge…
-
CLINICAL_TRIALS withdrawal · 2011-04-08Clinical Trial Update: To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity Conditioning [Phase 3]
A Phase 3 clinical trial evaluating adding Campath-1H (alemtuzumab) or ATG to fludarabine and low-dose busulfan conditioning for acute myelo…
-
EMA withdrawal · 2008-06-04EMA Application withdrawn: Lenalidomide Celgene Europe (lenalidomide) — Celgene Europe Limited
EMA withdrew thelenalidomide Celgene Europe application for myelodysplastic syndromes.
-
CLINICAL_TRIALS withdrawal · 2007-04-11Clinical Trial Update: The Efficacy of Coenzyme Q10 And Curcumin in Patients With Myelodysplastic Syndromes [Phase 1, Phase 2]
A clinical trial evaluating Coenzyme Q10 and Curcumin in myelodysplastic syndromes has been withdrawn, covering Phase 1 and Phase 2 cohorts.